PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

Ann: PHASE 2 RRV DATA PUBBLISHED IN PEER-REVIEWED JOURNAL

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.